Timing of ovarian stimulation in patients prior to gonadotoxic therapy: an analysis of 684 stimulations.

von Wolff, Michael; Capp, Edison; Jauckus, Julia; Strowitzki, Thomas; Germeyer, Ariane (2016). Timing of ovarian stimulation in patients prior to gonadotoxic therapy: an analysis of 684 stimulations. European journal of obstetrics & gynecology and reproductive biology, 199, pp. 146-149. Elsevier 10.1016/j.ejogrb.2016.02.006

Text 26927896_1-s2.0-S0301211516300422-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (276kB) | Request a copy

OBJECTIVE

Time to therapy initiation in patients requiring gonadotoxic therapy is crucial. This article evaluates the efficiency of random start ovarian stimulation in affected women.

STUDY DESIGN

Retrospective anonymous registry data analysis from 85 university and non-university fertility centres participating in the international network FertiPROTEKT. The study comprised 684 women undergoing ovarian stimulation for fertility preservation from 2007 to 2013. According to the time of stimulation initiation, days of ovarian stimulation, total dose of gonadotropins used, gonadotropin dose used per day, number of oocytes retrieved and incidence of ovarian hyperstimulation syndrome were analysed. Statistical analysis was performed using analysis of variance in case of continuous outcome variables and chi-square tests in case of categorical variables.

RESULTS

Among 684 women who underwent ovarian stimulation prior to gonadotoxic therapy 472 (69.0%) started ovarian stimulation between menstrual cycle day 1-5 (group A), 109 (15.9%) between day 6-14 (group B) and 103 (15.1%) after day 14 (group C). The days of stimulation (A: 10.8±2.4, B: 10.6±2.7, C: 11.5±2.2) and total dose of gonadotropins (A: 2496IU±980, B: 2529IU±940, C: 2970IU±1145) were significantly increased in group C. Numbers of obtained oocytes (Group A: 11.6±7.7, B: 13.9±9.1, C: 13.6±7.9) were significantly increased in group B and C, while the overall incidence of ovarian hyperstimulation syndrome III° was 0.15%.

CONCLUSION

The outcome of ovarian stimulation is similar after stimulation initiation during any phase of the menstrual cycles, supporting the concept of random-start ovarian stimulation before gonadotoxic therapy without disadvantage for the patient concerning later fertility preservation.

Interest & Impact

Downloads

2 since deposited on 10 May 2017
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item